REVIVE (Response to the Ebola Virus Vaccine)

Clinical trial NCT05992480 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05992480
Sponsor: Tulane University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2025-12-01
Primary completion: 2026-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.